An investigation on behalf of investors in bluebird bio Inc (NASDAQ:BLUE) shares over potential wrongdoing at bluebird bio Inc was announced and NASDAQ:BLUE stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 01/06/2015 --An investigation on behalf of current long-term investors in shares of bluebird bio Inc (NASDAQ:BLUE) shares was announced over potential breaches of fiduciary duties by certain officers and directors at bluebird bio.

Investors who purchased shares of bluebird bio Inc (NASDAQ:BLUE) have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain bluebird bio officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

bluebird bio Inc reported that its annual Total Revenue rose from $0.34 million in 2012 to $20.18 million in 2013. Shares of bluebird bio Inc (NASDAQ:BLUE) grew from $17.69 per share in May 2014 to as high as $94.49 per share on December 15, 2014.

On January 2, 2015, NASDAQ:BLUE shares closed at $91.26 per share.

Those who purchased shares of bluebird bio Inc (NASDAQ:BLUE) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com